Real World Efficacy and Tolerability of the Novel Monoclonal Antibodies as Compared to Rituximab for Neuromyelitis Optica Spectrum Disorder

Authors
Category Primary study
ConferenceACTRIMS Forum 2024
Year 2024
This article has no abstract
Epistemonikos ID: 1dd931f92a7edc9ca22619f3f33c94be134abc69
First added on: Dec 05, 2025